Nykredit A S Makes New $12.46 Million Investment in Humana Inc. $HUM

Key Points

• Nykredit A/S purchased 31,361 Humana shares worth approximately $12.46 million during the second quarter, while institutional investors collectively own 92.38% of the stock.
• Analyst sentiment has improved, with several firms raising price targets or upgrading the stock. However, the consensus rating remains Hold, with an average price target of $403.91.
• Humana reported quarterly EPS of $7.61, exceeding estimates, while revenue rose 26.2% year over year to $40.89 billion. The company also declared a quarterly dividend of $0.885 per share, representing a 0.9% yield.

Nykredit A S purchased a new stake in Humana Inc. (NYSE:HUM - Free Report) during the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 31,361 shares of the insurance provider's stock, valued at approximately $12,457,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in shares of Humana in the second quarter valued at approximately $4,138,160,000. Pzena Investment Management LLC bought a new position in Humana during the second quarter worth about $1,749,014,000. Capital International Investors grew its holdings in Humana by 113.9% during the fourth quarter. Capital International Investors now owns 5,818,008 shares of the insurance provider's stock valued at $1,490,239,000 after purchasing an additional 3,097,571 shares during the period. Norges Bank acquired a new position in shares of Humana in the 4th quarter valued at $456,632,000. Finally, Franklin Resources Inc. grew its stake in Humana by 914.5% in the fourth quarter. Franklin Resources Inc. now owns 1,255,665 shares of the insurance provider's stock valued at $321,613,000 after acquiring an additional 1,131,893 shares during the period. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several analysts have commented on HUM shares. Mizuho raised their target price on shares of Humana from $335.00 to $390.00 and gave the stock an "outperform" rating in a report on Monday, June 8th. Evercore upgraded shares of Humana from an "in-line" rating to an "outperform" rating and set a $480.00 price objective on the stock in a report on Wednesday, July 29th. Morgan Stanley raised shares of Humana from an "underweight" rating to an "equal weight" rating and boosted their price objective for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Truist Financial increased their target price on Humana from $320.00 to $415.00 and gave the stock a "hold" rating in a report on Tuesday, July 14th. Finally, Lake Street Capital initiated coverage on Humana in a research note on Thursday, July 30th. They issued a "buy" rating on the stock. Fourteen research analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $403.91.

Humana Price Performance

NYSE:HUM opened at $385.81 on Monday. Humana Inc. has a 12-month low of $163.11 and a 12-month high of $428.88. The firm has a market capitalization of $46.33 billion, a price-to-earnings ratio of 36.50, a P/E/G ratio of 2.39 and a beta of 0.74. The stock's 50 day moving average price is $388.62 and its two-hundred day moving average price is $311.75. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business had revenue of $40.89 billion during the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter in the previous year, the firm posted $6.27 EPS. Humana's revenue was up 26.2% compared to the same quarter last year. On average, analysts anticipate that Humana Inc. will post 9 earnings per share for the current year.

Humana Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Stockholders of record on Friday, October 30th will be paid a $0.885 dividend. The ex-dividend date is Friday, October 30th. This represents a $3.54 annualized dividend and a dividend yield of 0.9%. Humana's dividend payout ratio (DPR) is presently 33.49%.

About Humana

Humana Inc NYSE: HUM is a U.S.-based health insurance and health care services company focused primarily on government-sponsored programs. Its offerings include Medicare Advantage plans, Medicare prescription drug plans, Medicaid coverage and specialty insurance products, serving individuals, employers and government organizations.

Through its CenterWell business, Humana also provides senior-focused primary care, pharmacy services and home health care. These operations are designed to support coordinated care for older adults and other members with ongoing health care needs.

Humana was founded in 1961 as a nursing-home company and later expanded into hospital ownership before shifting its focus toward health insurance.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.